IN.PACT™ AV Access IDE Study

ClinicalTrials.gov ID: NCT03041467

Public ClinicalTrials.gov record NCT03041467. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Study of IN.PACT™ AV Access Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon vs. Standard PTA for the Treatment of Obstructive Lesions in the Native Arteriovenous Dialysis Fistulae (AVF)

Study identification

NCT ID: NCT03041467
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Medtronic Endovascular; Industry
Enrollment: 330 participants

Conditions and interventions

Conditions

Interventions

IN.PACT AV DCB Device
Standard Balloon Angioplasty Device

Device

Eligibility (public fields only)

Age range: 21 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 24, 2017
Primary completion: Dec 5, 2018
Completion: May 4, 2023
Last update posted: May 28, 2024

2017 – 2023

United States locations

U.S. sites: 21
U.S. states: 17
U.S. cities: 21

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham (UAB) Hospital	Birmingham	Alabama	35233	—
SKI Vascular Center	Tempe	Arizona	85281	—
Capital Nephrology Medical Group	Sacramento	California	95825	—
Florida Research Network	Gainesville	Florida	32605	—
Coastal Vascular and Interventional	Pensacola	Florida	32504	—
Christie Clinic Vein and Vascular Center	Champaign	Illinois	61822	—
Rush University Medical Center	Chicago	Illinois	60612	—
University of Iowa Hospitals and Clinics	Iowa City	Iowa	52242	—
King's Daughters Medical Center	Ashland	Kentucky	41101	—
Mayo Clinic	Rochester	Minnesota	55905	—
Holy Name Medical Center	Teaneck	New Jersey	07666	—
The Mount Sinai Hospital	New York	New York	10029	—
North Carolina Nephrology PA	Raleigh	North Carolina	27610	—
Cleveland Clinic	Cleveland	Ohio	44195	—
Dialysis Access Institute	Orangeburg	South Carolina	29118	—
Sanford University of South Dakota Medical Center	Sioux Falls	South Dakota	57105	—
University Surgical Associates	Chattanooga	Tennessee	37404	—
Dallas Nephrology Associates	Plano	Texas	75093	—
Sentara Vascular Specialists	Norfolk	Virginia	23507	—
Richmond Vascular Center	North Chesterfield	Virginia	23236	—
Vascular Institute of Virginia	Woodbridge	Virginia	22193	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03041467, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 28, 2024 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03041467 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →